The hidden strength of teams: how collaboration can build resilience

In the world of pharma, celebrating the thrill of a new product launch comes naturally. What’s harder, and often overlooked, is managing the portfolio that quietly sustains the business long after the fanfare fades.

Resilience – the importance of maintaining our well-being. Resilience isn’t always about standing strong – so how do we grow our own resilience?

Creativity cages - The surprising way to think out of the box

Pelage Pharmaceuticals’ alopecia treatment moves forward to phase 3 trial • La Roche-Posay launches global campaign to spotlight the visible and invisible impact of scars

Lilly and WHO Foundation partner to support global dementia action plan • MHRA marks 100 years of patient safety through biological standards

Novartis and Matchpoint Therapeutics agree on deal worth $1bn • GSK expands pipeline through $12bn deal with Hengrui • BMS acquires Orbital Therapeutics in $1.5bn deal • Pfizer’s Lorviqua recommended by NICE for lung cancer • Lilly’s early Alzheimer’s disease treatment gets EU approval • Roche’s small cell lung cancer therapy approved by FDA

How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?

Collecting the right data in the right way for the right reasons

The evolutionary lessons for Bayer’s management restructure

UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa